As of 2026-03-26, the Intrinsic Value of Asia Green Biotechnology Corp (ASIA.CN) is -0.26 CAD. This ASIA.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Asia Green Biotechnology Corp is -1,827.58%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Asia Green Biotechnology Corp (ASIA.CN) is overvalued by 1,827.58%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.26 - -0.26 | -0.26 | -1,827.58% |
| P/E | (0.00) - (0.00) | (0.00) | -117.3% |
| DDM - Stable | (0.23) - 1.48 | 0.62 | 4064.1% |
| DDM - Multi | (0.19) - 0.92 | (0.46) | -3178.0% |
| Market Cap (mil) | 0.36 |
| Beta | 0.39 |
| Outstanding shares (mil) | 24.16 |
| Enterprise Value (mil) | 0.60 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.27% |
| Cost of Debt | 5.00% |
| WACC | 4.64% |